Anath Shalev

Targeting Mash with Novel Small Molecule Txnip Inhibitor

National Institute of Diabetes and Digestive and Kidney Diseases · R01

Contact PI · $1.9M · University of Alabama at Birmingham

Txnip Regulation of Endogenous Beta Cell Mass

National Institute of Diabetes and Digestive and Kidney Diseases · R01

Contact PI · $4.4M · University of Alabama at Birmingham

Tissue and Organ Specific Human B Cell Immunity

National Institute of Allergy and Infectious Diseases · U19

PI · $1M · University of Alabama at Birmingham

Development of an Early Diagnostic Biomarker and Novel Treatment Strategy for T1D

National Institute of Diabetes and Digestive and Kidney Diseases · U01

Contact PI · $2.2M · University of Alabama at Birmingham

Verapamil for Beta Cell Survival Therapy in Type 1 Diabetes

Principal investigator · Completed · Phase 2

University of Alabama at Birmingham

Denosumab for Type 1 Diabetes

Site PI · Recruiting · Phase 1, Phase 2

City of Hope Medical Center